The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer

International Journal of Urology

Volumn 15, Issue 7, 2008, Pages 607-611

  Herrmann, Edwin ^a   Stöter, Eva ^a   Van Ophoven, Arndt ^a   Bierer, Stefan ^a   Bolenz, Christian ^b   Hertle, Lothar ^a   Wülfing, Christian ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF MANNHEIM   (Germany)

Author keywords

Bladder cancer; Lymph node metastasis; Lymphadenectomy; Lymphovascular invasion; Radical cystectomy

Indexed keywords

CISPLATIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; PACLITAXEL; VINBLASTINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER STAGING; COHORT ANALYSIS; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PELVIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; URINARY BLADDER NEOPLASMS; VASCULAR NEOPLASMS;

EID: 47249085614     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02059.x     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J. Clin. 2006 56 : 106 30.
2. Herr HW. Pathologic evaluation of radical cystectomy specimens. Cancer 2002 95 : 668 9.
3. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J. Clin. Oncol. 2001 19 : 666 75.
4. Madersbacher S, Hochreiter W, Burkhard F et al. Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J. Clin. Oncol. 2003 21 : 690 6.
5. Bassi P, Ferrante GD, Piazza N et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J. Urol. 1999 161 : 1494 7.
6. Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J. Urol. 2004 171 : 1830 4.
7. Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J. Urol. 2001 166 : 19 23.
8. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J. Urol. 2002 167 : 1295 8.
9. Herr HW, Donat SM. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J. Urol. 2001 165 : 62 4.
10. Shariat SF, Karakiewicz PI, Palapattu GS et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J. Urol. 2006 176 : 2414 22.
11. Leissner J, Ghoneim MA, Abol-Enein H et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J. Urol. 2004 171 : 139 44.
12. Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J. Urol. 1998 160 : 2015 9.
13. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J. Urol. 2003 169 : 946 50.
14. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J. Urol. 2003 169 : 943 5.
15. Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J. Clin. Oncol. 2005 23 : 2358 65.
16. Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J. Urol. 2004 172 : 85 9.
17. Stein JP, Skinner DG. Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer. BJU Int. 2003 92 : 12 7.
18. Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 2006 107 : 2368 74.
19. Leissner J, Koeppen C, Wolf HK. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy. J. Urol. 2003 169 : 955 60.
20. Lotan Y, Gupta A, Shariat SF et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J. Clin. Oncol. 2005 23 : 6533 9.
21. Quek ML, Stein JP, Nichols PW et al. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J. Urol. 2005 174 : 103 6.
22. Algaba F. Lymphovascular invasion as a prognostic tool for advanced bladder cancer. Curr. Opin. Urol. 2006 16 : 367 71.
23. Hara S, Miyake H, Fujisawa M et al. Prognostic variables in patients who have undergone radical cystectomy for transitional cell carcinoma of the bladder. Jpn. J. Clin. Oncol. 2001 31 : 399 402.
24. Logothetis CJ, Johnson DE, Chong C et al. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. J. Clin. Oncol. 1988 6 : 1590 6.